| |
| |
|
| Insider
Information: |
Connaughton Bernadette |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
55,064 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,188,989 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
55,064 |
|
|
| Total
Value |
$2,188,989 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Halozyme Therapeutics Inc |
HALO |
|
2023-05-05 |
40,286 |
2018-09-07 |
0 |
Premium* |
|
|
Syneos Health Inc |
SYNH |
Director |
2023-05-25 |
14,778 |
2019-11-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SYNH |
Syneos Health Inc |
Director |
– • – |
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,863 |
14,778 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
|
– • – |
2023-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
8,065 |
40,286 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
|
– • – |
2022-11-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,998 |
32,221 |
0 |
- |
|
| SYNH |
Syneos Health Inc |
Director |
– • – |
2022-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
2,839 |
9,915 |
0 |
- |
|
| SYNH |
Syneos Health Inc |
Director |
– • – |
2021-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,364 |
7,076 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2021-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,230 |
32,013 |
0 |
- |
|
| SYNH |
Syneos Health Inc |
Director |
– • – |
2020-05-27 |
4 |
A |
$62.43 |
$174,991 |
D/D |
2,803 |
4,712 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2020-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,829 |
26,783 |
0 |
- |
|
| SYNH |
Syneos Health Inc |
Director |
– • – |
2019-11-12 |
4 |
A |
$49.48 |
$94,457 |
D/D |
1,909 |
1,909 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2019-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
12,173 |
17,954 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2018-09-07 |
4 |
A |
$0.00 |
$0 |
D/D |
5,781 |
5,781 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
